-
-
Experimental pill targets nerve pain pathway, cutting opioid use after abdominal surgery
-
AI learns to spot tomato diseases using nearly 9,000 field images
Locust neurons detect PFAS at environmentally relevant levels, pointing to portable sensors
EyePoint’s Phase 3 fail sends stock spiraling amid next-gen AMD race
Summit, Akeso’s China approval celebration cut short as survival benefit degrades
In The News
- Experimental pill targets nerve pain pathway, cutting opioid use after abdominal surgery August 18, 2026 By News Staff
- Locust neurons detect PFAS at environmentally relevant levels, pointing to portable sensors August 18, 2026 By News Staff
- Summit, Akeso’s China approval celebration cut short as survival benefit degrades August 18, 2026 By News Staff
- Decades-old puzzle solved as scientists uncover cause of inflammatory bowel disease June 11, 2026 By News Staff
- Degradable sensors reveal hidden soil secrets after microbes nibble on them June 11, 2026 By News Staff
Biotechnology Today
more-
AI learns to spot tomato diseases using nearly 9,000 field images
A breakthrough in AI-driven crop disease detection is set to reduce harvest losses and chemical-related…
Locust neurons detect PFAS at environmentally relevant levels, pointing to portable sensors
Nature has spent billions of years fighting bacteria. AI could help us learn its secrets
Gene-edited beagles produce no detectable major dog allergen, early tests find
Teaching AI the biology of antibodies speeds drug discovery
Markets
more-
Weekly Market Review – Sept. 20, 2025
Stock Markets Equity markets continued their positive momentum this week, with major indices posting solid…
Bio Space
moreEyePoint’s Phase 3 fail sends stock spiraling amid next-gen AMD race
EyePoint’s quest to reduce treatment burden for patients with age-related…
Summit, Akeso’s China approval celebration cut short as survival benefit degrades
Ivonescimab notched its third approval in China last week, but…
J&J hands lymphoma bispecific CAR T back to AbelZeta
Johnson & Johnson secured rights to prizlon-cel in 2023 for…
Global News
moreCommon arthritis pill repurposed to boost hair regrowth in alopecia patients
Upadacitinib is a medication widely used for the treatment of…
Experimental pill targets nerve pain pathway, cutting opioid use after abdominal surgery
Opioids can be highly effective at relieving moderate to severe…
New cellular clues to complications of scleroderma
A study published in JCI Insight and led by Northwestern…
Common arthritis pill repurposed to boost hair regrowth in alopecia patients
Experimental pill targets nerve pain pathway, cutting opioid use after abdominal surgery
AI learns to spot tomato diseases using nearly 9,000 field images
Locust neurons detect PFAS at environmentally relevant levels, pointing to portable sensors
EyePoint’s Phase 3 fail sends stock spiraling amid next-gen AMD race
Summit, Akeso’s China approval celebration cut short as survival benefit degrades
New cellular clues to complications of scleroderma
Fast-spreading malaria parasite mutations in Uganda may weaken Africa’s most widely used malaria therapy
Nature has spent billions of years fighting bacteria. AI could help us learn its secrets
Gene-edited beagles produce no detectable major dog allergen, early tests find